FOLD
Price
$9.81
Change
+$0.08 (+0.82%)
Updated
Dec 20, 04:59 PM (EDT)
67 days until earnings call
ROIV
Price
$11.57
Change
+$0.07 (+0.61%)
Updated
Dec 20, 04:59 PM (EDT)
58 days until earnings call
Ad is loading...

FOLD vs ROIV

Header iconFOLD vs ROIV Comparison
Open Charts FOLD vs ROIVBanner chart's image
Amicus Therapeutics
Price$9.81
Change+$0.08 (+0.82%)
Volume$50.75K
CapitalizationN/A
Roivant Sciences
Price$11.57
Change+$0.07 (+0.61%)
Volume$115.2K
CapitalizationN/A
FOLD vs ROIV Comparison Chart
Loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FOLD vs. ROIV commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and ROIV is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (FOLD: $9.80 vs. ROIV: $11.57)
Brand notoriety: FOLD and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 127% vs. ROIV: 301%
Market capitalization -- FOLD: $2.93B vs. ROIV: $8.42B
FOLD [@Biotechnology] is valued at $2.93B. ROIV’s [@Biotechnology] market capitalization is $8.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 5 bullish TA indicator(s).

  • FOLD’s TA Score: 5 bullish, 5 bearish.
  • ROIV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both FOLD and ROIV are a good buy in the short-term.

Price Growth

FOLD (@Biotechnology) experienced а +4.70% price change this week, while ROIV (@Biotechnology) price change was -2.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

FOLD is expected to report earnings on Feb 26, 2025.

ROIV is expected to report earnings on Feb 17, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.42B) has a higher market cap than FOLD($2.93B). ROIV YTD gains are higher at: 3.028 vs. FOLD (-30.937). ROIV has higher annual earnings (EBITDA): 4.15B vs. FOLD (-9.2M). ROIV has more cash in the bank: 5.39B vs. FOLD (250M). ROIV has less debt than FOLD: ROIV (52.7M) vs FOLD (445M). FOLD has higher revenues than ROIV: FOLD (494M) vs ROIV (129M).
FOLDROIVFOLD / ROIV
Capitalization2.93B8.42B35%
EBITDA-9.2M4.15B-0%
Gain YTD-30.9373.028-1,022%
P/E RatioN/A2.09-
Revenue494M129M383%
Total Cash250M5.39B5%
Total Debt445M52.7M844%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDROIV
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
70%
Momentum
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
69%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 6 days ago
70%
View a ticker or compare two or three
Ad is loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SGLC33.010.34
+1.04%
SGI U.S. Large Cap Core ETF
DYNF51.740.49
+0.96%
iShares U.S. Equity Fac Rotation Act ETF
WBND19.670.09
+0.45%
Western Asset Total Return ETF
IBTM22.230.08
+0.34%
iShares iBonds Dec 2032 Term Trs ETF
INDY51.68-0.10
-0.19%
iShares India 50 ETF

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with ALDX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
+0.72%
ALDX - FOLD
45%
Loosely correlated
N/A
VCYT - FOLD
43%
Loosely correlated
+4.66%
RCKT - FOLD
42%
Loosely correlated
+2.03%
SRPT - FOLD
42%
Loosely correlated
-0.42%
DNLI - FOLD
41%
Loosely correlated
-0.14%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.61%
IMVT - ROIV
58%
Loosely correlated
+0.86%
ARGX - ROIV
46%
Loosely correlated
-0.35%
AXON - ROIV
43%
Loosely correlated
+2.59%
RARE - ROIV
42%
Loosely correlated
+1.73%
STOK - ROIV
41%
Loosely correlated
+3.36%
More